Table 3
Significance levels between the patient groups and controls as well as between patients who converted to AD at the follow up and patients who did not
| Significance levels | |||||
|---|---|---|---|---|---|
| TNFα | TGFβ | IL1β | Aβ42 | Tau | |
| All patients v controls | 0.046 | 0.002 | NS | 0.003 | 0.0001 |
| AD v MCI at follow up | NS | NS | NS | 0.042 | NS |
| MCI at follow up v controls | NS | 0.05 | NS | NS | 0.003 |
| AD at follow up v controls | 0.039 | 0.0004 | NS | 0.0001 | 0.0001 |
